Why the study?
Aging is accompanied by chronic inflammation and immunosenescence that affect myocardial disease susceptibility and prognosis, highlighting the potential value of monitoring immune-aging trajectories and incorporating aging context into research.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May inform risk stratification in age-related myocardial disease; leaves open need for prospective validation before clinical use.
Life expectancy has steadily increased over the past century, as has the occurrence of age-related diseases, most notably myocardial diseases. Aging is often accompanied by increased low-grade chronic inflammation, accumulation of terminally differentiated T-cells poised with proinflammatory phenotypes, and clonal hematopoiesis. These systemic alterations have been consistently shown to impact myocardial physiology, individual susceptibility to heart diseases and long-term heart disease prognosis. In recent years, progress has been made in understanding the interindividual (cross-sectional) and intraindividual (longitudinal) variability in the global immunosenescence profile, and novel immune-aging metric-based scoring systems bearing potential to predict cardiovascular events have emerged. We herein suggest that monitoring the patients’ individual immunosenescence trajectories, in addition to the classic cardiological work-up, could provide valuable diagnostic/prognostic information. Similarly, we propose that basic research in cardio-immunology could attain a deeper mechanistic understanding of age-related diseases and a more meaningful translational impact if the ‘aging context’ was embraced more systematically.
No takes yet. Share an insight, caveat, or question.
Appel et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: